Displaying 141 - 145 of 198
Mon 09 June 2014
The Scottish Medicines Consortium (SMC) decided today that the cancer drug, Abraxane® would not be made routinely available on the NHS in Scotland.Read More about 'SMC says 'no' to Abraxane'
Wed 07 May 2014
Younger patients, including those in their 30s and 40s, are more likely than older patients to experience delayed diagnosis and misdiagnosis, a major new survey has found.Read More about 'Younger patients diagnosed later'
Fri 02 May 2014
We are delighted to announce NHS England has referred the development of a pancreatic cancer Clinical Guideline and Quality Standard to the National Institute for Health and Care Excellence (NICE)!Read More about 'New clinical guideline and quality standard for pancreatic cancer'
Tue 29 April 2014
Cancer Research UK announces an increase in research of hard-to-treat cancers including pancreatic cancer as well as lung, oesophageal and brain tumours.Read More about 'Welcome investment from Cancer Research UK'
Thu 20 March 2014
Today the Cancer Drugs Fund Panel (CDF) announced its decision to approve Abraxane® (Paclitaxel Albumin), for inclusion on the list of cancer drugs that are made available on the NHS prior to an assessment by the National Institute for Care and Health Excellence (NICE).Read More about 'Abraxane added to Cancer Drugs Fund list!'